Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. - Wikidata - wikimedia - TriplyDB

Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction.

Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction.

http://www.wikidata.org/entity/Q46582849

about

Are the changes in the peripheral brain-derived neurotrophic factor levels due to platelet activation?Antidepressants and cardiovascular adverse events: A narrative review Cardiovascular considerations in antidepressant therapy: an evidence-based review Depression and cardiovascular comorbidity Cardiovascular disease risk factors, depression symptoms and antidepressant medicine use in the Look AHEAD (Action for Health in Diabetes) clinical trial of weight loss in diabetes.Effect of collaborative care for depression on risk of cardiovascular events: data from the IMPACT randomized controlled trial.Antidepressants, autonomic function and mortality in patients with coronary heart disease: data from the Heart and Soul Study.Adverse cardiovascular events in antidepressant trials involving high-risk patients: a systematic review of randomized trials.Elevated stress-hemoconcentration in major depression is normalized by antidepressant treatment: secondary analysis from a randomized, double-blind clinical trial and relevance to cardiovascular disease risk.History of depression and survival after acute myocardial infarction.Treatment of depression after coronary artery bypass surgery: a randomized controlled trial Position paper on the importance of psychosocial factors in cardiology: Update 2013 Anxiety and depression disorders in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.The effect of a primary care practice-based depression intervention on mortality in older adults: a randomized trial Stress, depression, and coronary artery disease: modeling comorbidity in female primates.The relationship between depression, anxiety, and cardiovascular outcomes in patients with acute coronary syndromes.Enhanced depression care for patients with acute coronary syndrome and persistent depressive symptoms: coronary psychosocial evaluation studies randomized controlled trial.Up-beat UK: a programme of research into the relationship between coronary heart disease and depression in primary care patients.Depression, antidepressant use and mortality in later life: the Health In Men Study A prospective examination of antidepressant use and its correlates in patients with acute coronary syndrome.Prevalence of antidepressant prescription or use in patients with acute coronary syndrome: a systematic review.Psychological and social factors in coronary heart disease.Effects of antidepressants on IP-10 production in LPS-activated THP-1 human monocytes.Symptoms of depression in a Hispanic primary care population with and without chronic medical illnesses.Effects of selective serotonin reuptake inhibitors on platelet function: mechanisms, clinical outcomes and implications for use in elderly patients.Differential associations between specific depressive symptoms and cardiovascular prognosis in patients with stable coronary heart disease.Management of depression in patients with coronary heart disease: association, mechanisms, and treatment implications for depressed cardiac patients.Antidepressant use and risk of coronary heart disease: meta-analysis of observational studies.Anti-depressant medication use and C-reactive protein: results from two population-based studies Antidepressant medication use and future risk of cardiovascular disease: the Scottish Health Survey.Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines.Is placebo useful in the treatment of major depression in clinical practice?Pathophysiological basis of cardiovascular disease and depression: a chicken-and-egg dilemma.Characteristics of depression remission and its relation with cardiovascular outcome among patients with chronic heart failure (from the SADHART-CHF Study)The expanded biology of serotonin.Depressive symptoms and risk of new cardiovascular events or death in patients with myocardial infarction: a population-based longitudinal study examining health behaviors and health care interventions.Effect of escitalopram on mental stress-induced myocardial ischemia: results of the REMIT trial.Effects of long-term sertraline treatment and depression on coronary artery atherosclerosis in premenopausal female primates A shared parameter model for the estimation of longitudinal concomitant intervention effects Associations of preexisting depression and anxiety with hospitalization in patients with cardiovascular disease.

P2860

Q26750898-B3BAB07C-B2E4-4A14-BF61-01E87CABC559 Q26771629-22F3817A-BA45-43C2-8F36-E0AE705AB6FD Q27021843-952D34DF-8A38-472A-BC97-A5E541570A7D Q28210833-2CE5E75C-EDA9-4320-8AEA-00A4CF61E355 Q30500360-69B90F03-C720-4F26-B1FC-3A3A6B4D346B Q30724107-337BBB8A-571E-41F2-9DE0-891413821D6B Q30838926-9C1C5D74-5B78-4CFF-99F8-3BD0B8847F92 Q33154720-07774351-E00E-4742-A3E3-76595553A6A9 Q33382718-8B328387-B50E-4177-B370-AE32D8633179 Q33413601-CF26B89A-7A54-46FA-B18A-64A9772F57A9 Q33427334-4753A9C0-3EEF-49B7-BAAB-B876E118E24B Q33576193-0F839950-F60E-4E49-9723-973B1C6AAAD3 Q33612055-6B1FF1AF-5A24-48BB-B0FB-863746BC408E Q33638700-3D8BD7DE-57B5-4B81-9DBC-320B6F67D630 Q33711111-CC68A475-F2E0-4AA2-9324-707A0564C4F4 Q33868089-F1044E17-8386-4F4B-B91A-2AA150DB387D Q33900047-8369CE70-53EB-495E-A4E0-69C97D154ADD Q33909445-37599936-87E8-4D84-A20F-B943C9723609 Q33932999-EFAFF1C9-4E09-4011-BAC4-D6B792716A2D Q34081691-FB3F08DA-98BE-4CF1-B08F-93327B156450 Q34087791-6F63FFD1-51B2-421E-BA14-BCBF9571E411 Q34137895-2539BF08-2530-4D1F-9E8D-E7B5754BEBC1 Q34158301-31B2B23F-7F05-47AF-B21B-FE870A13E2D1 Q34163704-16927828-F334-47C1-A8ED-AB53E6FB148D Q34182611-691014D0-9F0A-4E76-A90F-CAF21FD8D392 Q34193348-97D096DE-6D8E-4E48-AF0F-CF7B345A4C0C Q34384552-BE12BC12-4DBA-4822-A6E8-70C360373556 Q34410894-272FE321-9A11-48F4-BF63-59856BD73470 Q34459786-7AC0BBBB-5C8B-4316-B56B-13FBEBBD8B4F Q34571252-C357C860-B644-4D04-B05E-4F0A754F59CD Q34590507-836579EC-1D1F-4518-9AEA-B217E89880EE Q34653993-CD78E195-D0DD-4EA5-A8B1-102E3C19B03B Q34655157-880FEF98-C93E-45F6-AE07-F43840698781 Q34777512-EF9F620C-EBC1-4CD2-977C-74E7536FECC6 Q34993925-DC4D0BD3-27AC-4B53-AC49-56AA9757BA94 Q35005004-B9094BD3-81BF-4EB0-BE3F-FC022FC34661 Q35230653-2DC4BBAD-7094-408C-838C-E14645FDA955 Q35417719-256A1E67-7AA0-4EB3-BEE5-494A6D96EE9A Q35452071-1D1C075D-572F-4859-BC33-70579FE55794 Q35460879-5187D849-2F1E-4EAF-A644-F433430C2BB3

P2860

Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction.

http://www.wikidata.org/entity/Q46582849

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Effects of antidepressant medi ...... s after myocardial infarction.

@en

Effects of antidepressant medi ...... s after myocardial infarction.

@nl

type

label

Effects of antidepressant medi ...... s after myocardial infarction.

@en

Effects of antidepressant medi ...... s after myocardial infarction.

@nl

prefLabel

Effects of antidepressant medi ...... s after myocardial infarction.

@en

Effects of antidepressant medi ...... s after myocardial infarction.

@nl

P1433

Q46582849-A43006C3-2F5C-48F8-BC51-909901367AA7

P1476

Q46582849-1D228375-6E8F-49C0-8A2C-E824E738B691

P2093

Q46582849-125CB35C-806D-4DDC-A41E-AF678A44425E

Q46582849-30ADF5A2-2B86-471D-B637-4D0AB8C46F22

Q46582849-7E69C75F-5DFD-48A5-825C-7D6A0C5B5AFE

Q46582849-812851B3-57E8-436F-ADB2-FC6FF61BB20A

Q46582849-8B500386-07BB-4EB9-B217-A670A4412663

Q46582849-96F3AD3C-7569-4442-BF0F-5A5D8513482F

Q46582849-A9C8419D-8179-42F3-8AF7-922CBC4845C1

Q46582849-D6F8B78A-8713-4457-8988-A2C3E0EE0D1B

Q46582849-DB5F717A-0C90-4B60-9FC9-5E1454D86CDF

Q46582849-E52D15C1-10C7-4BCA-A8CA-89EACFCE508D

P304

Q46582849-3FFE436F-95A0-4AB0-92F5-6679AB17DAB5

P31

Q46582849-963A79E7-BCAC-4B57-A3B2-AF4E033C1AE0

P356

Q46582849-860FAFD9-AED5-4535-BB98-2798D18525E8

P407

Q46582849-FCDA7DC8-529C-4D9D-A6BE-2EDCB37717CE

P433

Q46582849-A2F89177-E813-4660-A2D8-B82463CCFA31

P478

Q46582849-F2112D9E-6EB8-4A72-9C9B-D5BB77B49B85

P50

Q46582849-61D78CE3-091F-4B5D-971C-298F5D103490

P577

Q46582849-65624193-A732-4557-BF86-943A0A7EC4E0

P698

Q46582849-4BE3E54D-DCB1-41CA-9DAB-AC04C47229E2

P921

Q46582849-67070B27-6F90-467B-A0DB-22BA2C0BACC0

Q46582849-DE9C6DEE-0C51-4918-83E6-F920046FA0DD

P356

ARCHPSYC.62.7.792

P1433

JAMA Psychiatry

P1476

Effects of antidepressant medi ...... s after myocardial infarction.

@en

P2093

Allan S Jaffe

http://www.w3.org/2001/XMLSchema#string

C Barr Taylor

http://www.w3.org/2001/XMLSchema#string

Diane Catellier

http://www.w3.org/2001/XMLSchema#string

James A Blumenthal

http://www.w3.org/2001/XMLSchema#string

John Shuster

http://www.w3.org/2001/XMLSchema#string

Marston E Youngblood

http://www.w3.org/2001/XMLSchema#string

Matthew M Burg

http://www.w3.org/2001/XMLSchema#string

Peter G Kaufmann

http://www.w3.org/2001/XMLSchema#string

Ranga Krishnan

http://www.w3.org/2001/XMLSchema#string

Richard C Veith

http://www.w3.org/2001/XMLSchema#string

P304

792-798

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHPSYC.62.7.792

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P50

ENRICHD Investigators

P577

2005-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15997021

http://www.w3.org/2001/XMLSchema#string

P921